Center of Excellence of the European Union
 
Set page width to 1024
Login
 
k1.jpg

Karoly Liliom

Dictionary
Publications
Publications

Articles

1.   Varga A, Gráczer E, Chaloin L, Liliom K, Závodszky P, Lionne C and Vas M (2013) [23201309]
  Selectivity of kinases on the activation of tenofovir, an anti-HIV agent.
  Eur J Pharm Sci 48, 307-15
2.   Cervenak J, Bender B, Schneider Z, Magna M, Carstea BV, Liliom K, Erdei A, Bosze Z and Kacskovics I (2011) [21148035]
  Neonatal FcR overexpression boosts humoral immune response in transgenic mice.
  J Immunol 186, 959-68
3.   Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C and Vas M (2011) [21505655]
  Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues.
  Mol Biosyst 7, 1863-73
4.   Bolen AL, Naren AP, Yarlagadda S, Beranova-Giorgianni S, Chen L, Norman D, Baker DL, Rowland MM, Best MD, Sano T, Tsukahara T, Liliom K, Igarashi Y and Tigyi G (2011) [21393252]
  The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation.
  J Lipid Res 52, 958-70
5.   Iliás A, Liliom K, Greiderer-Kleinlercher B, Reitinger S and Lepperdinger G (2011) [21840987]
  Unbinding of hyaluronan accelerates the enzymatic activity of bee hyaluronidase.
  J Biol Chem 286, 35699-707
6.   Kovacs E, Tóth J, Vértessy BG and Liliom K (2010) [19910470]
  Dissociation of calmodulin-target peptide complexes by the lipid mediator sphingosylphosphorylcholine: implications in calcium signaling.
  J Biol Chem 285, 1799-808
7.   Kovacs E, Tompa P, Liliom K and Kalmar L (2010) [20212158]
  Dual coding in alternative reading frames correlates with intrinsic protein disorder.
  P Natl Acad Sci Usa 107, 5429-34
8.   Szeltner Z, Morawski M, Juhász T, Szamosi I, Liliom K, Csizmók V, Tölgyesi F and Polgár L (2010) [20869470]
  GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase.
  Bba-proteins Proteom 1804, 2162-76
9.   Kovacs E, Xu L, Pasek DA, Liliom K and Meissner G (2010) [20851108]
  Regulation of ryanodine receptors by sphingosylphosphorylcholine: involvement of both calmodulin-dependent and -independent mechanisms.
  Biochem Bioph Res Co 401, 281-6
10.   Kovacs E, Harmat V, Tóth J, Vértessy BG, Módos K, Kardos J and Liliom K (2010) [20522785]
  Structure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactions.
  FASEB J 24, 3829-39
11.   Lankalapalli RS, Baksa A, Liliom K and Bittman R (2010) [20209561]
  Synthesis and properties of a photoactivatable analogue of psychosine (beta-Galactosylsphingosine).
  ChemMedChem 5, 682-6
12.   Pál-Gábor H, Gombos L, Micsonai A, Kovács E, Petrik E, Kovács J, Gráf L, Fidy J, Naiki H, Goto Y, Liliom K and Kardos J (2009) [19432419]
  Mechanism of lysophosphatidic acid-induced amyloid fibril formation of beta(2)-microglobulin in vitro under physiological conditions.
  Biochemistry-us 48, 5689-99
13.   Kovács E and Liliom K (2008) [17979830]
  Sphingosylphosphorylcholine as a novel calmodulin inhibitor.
  Biochem J 410, 427-37
14.   Fujiwara Y, Osborne DA, Walker MD, Wang DA, Bautista DA, Liliom K, Van Brocklyn JR, Parrill AL and Tigyi G (2007) [17114791]
  Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.
  J Biol Chem 282, 2374-85
15.   Liliom K, Tsukahara T, Tsukahara R, Zelman-Femiak M, Swiezewska E and Tigyi G (2006) [17092771]
  Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
  Bba-mol Cell Biol L 1761, 1506-14
16.   Durgam GG, Virag T, Walker MD, Tsukahara R, Yasuda S, Liliom K, van Meeteren LA, Moolenaar WH, Wilke N, Siess W, Tigyi G and Miller DD (2005) [16033271]
  Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
  J Med Chem 48, 4919-30
17.   Kern A, Szentpétery Z, Liliom K, Bakos E, Sarkadi B and Váradi A (2004) [14759224]
  Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.
  Biochem J 380, 549-60
18.   Szentpétery Z, Kern A, Liliom K, Sarkadi B, Váradi A and Bakos E (2004) [15252017]
  The role of the conserved glycines of ATP-binding cassette signature motifs of MRP1 in the communication between the substrate-binding site and the catalytic centers.
  J Biol Chem 279, 41670-8
19.   Virag T, Elrod DB, Liliom K, Sardar VM, Parrill AL, Yokoyama K, Durgam G, Deng W, Miller DD and Tigyi G (2003) [12695531]
  Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.
  Mol Pharmacol 63, 1032-42
20.   Meyer zu Heringdorf D, Liliom K, Schaefer M, Danneberg K, Jaggar JH, Tigyi G and Jakobs KH (2003) [14623109]
  Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors.
  FEBS Lett 554, 443-9
21.   Yokoyama K, Baker DL, Virag T, Liliom K, Byun HS, Tigyi G and Bittman R (2002) [12069841]
  Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
  Bba-mol Cell Biol L 1582, 295-308
22.   Wang DA, Lorincz Z, Bautista DL, Liliom K, Tigyi G and Parrill AL (2001) [11604399]
  A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
  J Biol Chem 276, 49213-20
23.   Liliom K, Sun G, Bünemann M, Virág T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G and Pott L (2001) [11256963]
  Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.
  Biochem J 355, 189-97
24.   Harmat V, Böcskei Z, Náray-Szabó G, Bata I, Csutor AS, Hermecz I, Arányi P, Szabó B, Liliom K, Vértessy BG and Ovádi J (2000) [10731425]
  A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.
  J Mol Biol 297, 747-55
25.   Orosz F, Wágner G, Liliom K, Kovács J, Baróti K, Horányi M, Farkas T, Hollán S and Ovádi J (2000) [10655478]
  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.
  P Natl Acad Sci Usa 97, 1026-31
26.   Parrill AL, Wang D, Bautista DL, Van Brocklyn JR, Lorincz Z, Fischer DJ, Baker DL, Liliom K, Spiegel S and Tigyi G (2000) [10982820]
  Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.
  J Biol Chem 275, 39379-84
27.   Liliom K, Wágner G, Pácz A, Cascante M, Kovács J and Ovádi J (2000) [10903506]
  Organization-dependent effects of toxic bivalent ions microtubule assembly and glycolysis.
  Eur J Biochem 267, 4731-9
28.   Tigyi G, Fischer DJ, Baker D, Wang DA, Yue J, Nusser N, Virag T, Zsiros V, Liliom K, Miller D and Parrill A (2000) [10818440]
  Pharmacological characterization of phospholipid growth-factor receptors.
  Ann Ny Acad Sci 905, 34-53
29.   Liliom K, Bünemann M, Sun G, Miller D, Desiderio DM, Brandts B, Bender K, Pott L, Nusser N and Tigyi G (2000) [10818471]
  Sphingosylphosphorylcholine is a bona fide mediator regulating heart rate.
  Ann Ny Acad Sci 905, 308-10
30.   Liliom K, Wágner G, Kovács J, Comin B, Cascante M, Orosz F and Ovádi J (1999) [10529410]
  Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro: decreased sensitivity to copper toxicity.
  Biochem Bioph Res Co 264, 605-10
31.   Liliom K, Guan Z, Tseng JL, Desiderio DM, Tigyi G and Watsky MA (1998) [9575804]
  Growth factor-like phospholipids generated after corneal injury.
  Am J Physiol 274, C1065-74
32.   Liliom K, Fischer DJ, Virág T, Sun G, Miller DD, Tseng JL, Desiderio DM, Seidel MC, Erickson JR and Tigyi G (1998) [9593679]
  Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations.
  J Biol Chem 273, 13461-8
33.   Fischer DJ, Liliom K, Guo Z, Nusser N, Virág T, Murakami-Murofushi K, Kobayashi S, Erickson JR, Sun G, Miller DD and Tigyi G (1998) [9855625]
  Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
  Mol Pharmacol 54, 979-88
34.   Tigyi J, Tigyi G, Liliom K and Miledi R (1997) [9000427]
  Local anesthetics inhibit receptors coupled to phosphoinositide signaling in Xenopus oocytes.
  Pflug Arch Eur J Phy 433, 478-87
35.   Ovádi J , Vértessy B G , Kovács J , Orosz F , Liliom K and Wágner G (1997) [-100008651]
  Multiple Functions of Glycolytic Kinases and Microtubular Proteins
  Cell Biol Int 21, 915-916
36.   Yakubu MA, Liliom K, Tigyi GJ and Leffler CW (1997) [-100010624]
  Role of lysophosphatidic acid in endothelin-1- and hematoma-induced alteration of cerebral microcirculation
  Am J Physiol-reg I 42, R703-9
37.   Yakubu MA, Liliom K, Tigyi GJ and Leffler CW (1997) [9277558]
  Role of lysophosphatidic acid in endothelin-1- and hematoma-induced alteration of cerebral microcirculation.
  Am J Physiol 273, R703-9
38.   Bünemann M, Liliom K, Brandts BK, Pott L, Tseng JL, Desiderio DM, Sun G, Miller D and Tigyi G (1996) [8896446]
  A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes.
  EMBO J 15, 5527-34
39.   Bittman R, Swords B, Liliom K and Tigyi G (1996) [9026536]
  Inhibitors of lipid phosphatidate receptors: N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids.
  J Lipid Res 37, 391-8
40.   Guo Z, Liliom K, Fischer DJ, Bathurst IC, Tomei LD, Kiefer MC and Tigyi G (1996) [8962057]
  Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.
  P Natl Acad Sci Usa 93, 14367-72
41.   Liliom K, Bittman R, Swords B and Tigyi G (1996) [8794902]
  N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
  Mol Pharmacol 50, 616-23
42.   Liliom K, Murakami-Murofushi K, Kobayashi S, Murofushi H and Tigyi G (1996) [8638656]
  Xenopus oocytes express multiple receptors for LPA-like lipid mediators.
  Am J Physiol 270, C772-7
43.   Molnár A, Liliom K, Orosz F, Vértessy BG and Ovádi J (1995) [8566178]
  Anti-calmodulin potency of indol alkaloids in in vitro systems.
  Eur J Pharmacol 291, 73-82
44.   Liliom K, Lehotzky A, Molnár A and Ovádi J (1995) [8572281]
  Characterization of tubulin-alkaloid interactions by enzyme-linked immunosorbent assay.
  Anal Biochem 228, 18-26
45.   Lehotzky A, Telegdi M, Liliom K and Ovádi J (1993) [8098705]
  Interaction of phosphofructokinase with tubulin and microtubules. Quantitative evaluation of the mutual effects.
  J Biol Chem 268, 10888-94
46.   Orosz F, Liliom K, Barkhudaryan NA, Horváth L and Ovádi J (1992) [1622396]
  Effects of calmodulin antagonists on antibody binding to calmodulin. Distinct conformers of calmodulin induced by the binding of drugs.
  Biochem J 284 (Pt 3), 803-8
47.   Liliom K, Orosz F, Horváth L and Ovádi J (1991) [1919032]
  Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin.
  J Immunol Methods 143, 119-25
48.   Orosz F, Telegdi M, Liliom K, Solti M, Korbonits D and Ovádi J (1990) [2147457]
  Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
  Mol Pharmacol 38, 910-6

Books or book chapters

1.   Liliom K, Wagner G, Orosz F, Kovacs J and Ovadi J (2000)
  Implications of cytoarchitectural analysis.
  Technological and Medical implications of metabolic control analysis. , 183-190
2.   Wágner G, Liliom K, Oláh J, Orosz F and Ovádi J (2000)
  Supramolecular organization-dependent responses to stimuli
  Animating the cellular map , 201-204
3.   Tigyi G, Liliom K, Fischer DJ and Guo Z (1999)
  Phospholipid growth factors: Identification and mechanism of action.
  CRC volume on lipid second messengers. , 51-81
4.   Ovadi J, Vertessy BG, Kovacs J, Wagner G, Liliom K and Orosz F (1999)
  Interrelationship of cytoarchitecture and glucose metabolism.
  From Symbiosis to Eukariotism-Endocytobiology; VII. , 517-532
5.   Tigyi G, Fischer DJ, Liliom K, Guo Z, Virag T, Sun G, Miller DD, Murakami-Murofushi K, Kobayaschi S and Erikson JR (1998)
  Determinants of receptor subtype specificity in the LPA-like lipid mediator family.
  Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury 4. , 245-252